Head & Neck Cancers
Nivolumab Hailed as “Game Changer” in Head and Neck Cancer
Read More >>
Nivolumab Improves Survival in Phase III Head and Neck Cancer Study
Read More >>
View Free CME from PER >>
Strains of Oral HPV Increases Risk of Head and Neck Cancers
Patients With Low-Risk Thyroid Microcarcinoma Benefit More With Active Surveillance
Promising Immuno-Oncology Approaches in the Management of Squamous Cell Carcinoma of the Head and Neck
Coexisting BRAF/TERT Mutations Predict Aggressive Thyroid Cancer
Nodule Size Should Not Determine Biopsy Decision in Thyroid Cancer
Pazopanib's Activity in Thyroid Cancer Not Predicted by Thyroglobulin
Tumor Profiling Identifies Potential Biomarkers for Vandetanib in MTC
View More >>
- A Network of Your Peers
View more >>
Dr. Mukherjee on Radioactive Iodine Treatment of Thyroid Cancer and Risk of MDS
Dr. Burtness on Emerging Immunotherapies in Head and Neck Cancer
Dr. Brose on Unique Elements of the Lenvatinib Trial
John Copland on Patient-Derived Xenografts in Anaplastic Thyroid Cancer
Importance of Multidisciplinary Thyroid Cancer Care
In this discussion, panelists explore the importance of multidisciplinary care for patients with locally advanced or metastatic thyroid cancer.
Treatment Selection in Advanced MTC
In this segment, panelists discuss the frontline treatment selection for patients with advanced medullary thyroid cancer who are not candidates for surgery.
Medullary Thyroid Cancer: Advances and Challenges
Moderated by Ezra Cohen, MD, this panel discussion includes expert perspectives from Eric J. Sherman, MD, Steven I. Sherman, MD, R. Michael Tuttle, MD, and Lori J. Wirth, MD.
8th Annual Multidisciplinary Symposium on Head and Neck Cancer: Medical Crossfire
CME activity worth 2.0 CME credits led by James Tate Thigpen, MD.
Most Popular Right Now
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2015
Intellisphere, LLC. All Rights Reserved.